Italy · Delayed Price · Currency is EUR Insulet Company Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.
The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface.
It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy.
The company sells its products to end-users through the pharmacy channel; and independent distributors.
Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
| Country | United States |
| Founded | 2000 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 3,900 |
| CEO | Ashley McEvoy |
Contact Details
Address: 100 Nagog Park Acton, Delaware 01720 United States | |
| Phone | 978 600 7000 |
| Website | insulet.com |
Stock Details
| Ticker Symbol | 1PODD |
| Exchange | Borsa Italiana |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Ashley McEvoy | Chief Executive Officer |
| Ana Chadwick | Chief Financial Officer |
| Prem Singh | Chief Operating Officer |
| June Lazaroff | Head of Investor Relations |